Steven Lichtman's Stock Ratings

Oppenheimer Analyst

Steven Lichtman is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/26/2024

Overall Average Return

22.8%

Smart Score

72.2%

Overall Average Return Percentile

82nd

Number of Ratings

34
Buy NowGet Alert
07/26/2024DXCMBuy Now
DexCom
$63.0582.39%$150 → $115MaintainsOutperformGet Alert
06/10/2024TNDMBuy Now
Tandem Diabetes Care
$39.6646.26%$47 → $58MaintainsOutperformGet Alert
05/15/2024ALCBuy Now
Alcon
$93.2010.52% → $103UpgradePerform → OutperformGet Alert
05/09/2024BWAYBuy Now
BrainsWay
$7.3749.25%$10 → $11MaintainsOutperformGet Alert
05/07/2024RXSTBuy Now
RxSight
$44.5161.76%$61 → $72MaintainsOutperformGet Alert
05/03/2024ZBHBuy Now
Zimmer Biomet Holdings
$111.2439.34%$150 → $155MaintainsOutperformGet Alert
04/05/2024ANGOBuy Now
AngioDynamics
$7.5159.79% → $12UpgradePerform → OutperformGet Alert
02/29/2024RXSTBuy Now
RxSight
$44.5137.05%$54 → $61MaintainsOutperformGet Alert
02/29/2024MMSIBuy Now
Merit Medical Systems
$85.162.16%$82 → $87MaintainsOutperformGet Alert
02/21/2024MDTBuy Now
Medtronic
$78.9216.58%$89 → $92MaintainsPerformGet Alert
02/01/2024BSXBuy Now
Boston Scientific
$75.11-9.47%$58 → $68MaintainsPerformGet Alert
01/29/2024RXSTBuy Now
RxSight
$44.5121.32%$50 → $54MaintainsOutperformGet Alert
01/16/2024RXSTBuy Now
RxSight
$44.5112.33%$46 → $50MaintainsOutperformGet Alert
01/08/2024RXSTBuy Now
RxSight
$44.513.35%$38 → $46MaintainsOutperformGet Alert
11/16/2023BWAYBuy Now
BrainsWay
$7.37-18.59%$5.5 → $6MaintainsOutperformGet Alert
09/19/2023MODDBuy Now
Modular Medical
$1.46139.73% → $3.5ReiteratesOutperform → OutperformGet Alert
08/23/2023MDTBuy Now
Medtronic
$78.9212.78% → $89ReiteratesPerform → PerformGet Alert
08/08/2023RXSTBuy Now
RxSight
$44.51-23.61%$29 → $34MaintainsOutperformGet Alert
08/02/2023ZBHBuy Now
Zimmer Biomet Holdings
$111.2441.14% → $157ReiteratesOutperform → OutperformGet Alert
07/28/2023BSXBuy Now
Boston Scientific
$75.11-21.45%$58 → $59MaintainsPerformGet Alert
05/19/2023MODDBuy Now
Modular Medical
$1.46139.73%$6 → $3.5MaintainsOutperformGet Alert
05/18/2023BWAYBuy Now
BrainsWay
$7.37-32.16% → $5ReiteratesOutperform → OutperformGet Alert
05/09/2023CFMSBuy Now
Conformis
DowngradeOutperform → PerformGet Alert
04/13/2023RXSTBuy Now
RxSight
$44.51-48.33% → $23Initiates → OutperformGet Alert
03/30/2023CSUBuy Now
Constellation Software
$2250 → $2500MaintainsMarket PerformGet Alert
02/06/2023ZBHBuy Now
Zimmer Biomet Holdings
$111.2427.65%$120 → $142MaintainsOutperformGet Alert
11/23/2022MDTBuy Now
Medtronic
$78.927.71%$106 → $85DowngradeOutperform → PerformGet Alert
11/11/2022CFMSBuy Now
Conformis
$1.25 → $8MaintainsOutperformGet Alert
01/31/2022PODDBuy Now
Insulet
$195.7040.52%$300 → $275UpgradePerform → OutperformGet Alert
12/17/2021MDTBuy Now
Medtronic
$78.9272.34%MaintainsOutperformGet Alert
11/24/2021MDTBuy Now
Medtronic
$78.9283.74%MaintainsOutperformGet Alert
09/04/2020COOBuy Now
Cooper Companies
$92.72266.7%$82.5 → $85MaintainsPerformGet Alert
03/06/2015COOBuy Now
Cooper Companies
$92.7291.98%$42.5 → $44.5MaintainsPerformGet Alert
12/16/2014COOBuy Now
Cooper Companies
$92.7283.35% → $42.5Initiates → PerformGet Alert